Methylation of the CASP8 gene has been associated with low levels of caspase-8 expression, reduced response to chemotherapeutic agents and poor outcome in a number of different cancer types including medulloblastoma [24] and neuroblastoma [25], [26], although this remains controversial at least in neuroblastoma [27]. The gene discussed is CASP8; the disease is cancer.